Risk of Long-term Care Admissions Among Medicare Patients Treated with Pimavanserin or Other Atypical Antipsychotics for Parkinson’s Disease Psychosis
Objective: To examine all-cause long-term care (LTC) admission risk among PDP patients treated with atypical antipsychotic (AAP). Background: Risk of LTC-admissions associated with off-label AAPs…Neuropsychological evaluation of cerebellar cognitive function in a series of patients with genetically confirmed CANVAS.
Objective: We aim to present the cerebellar cognitive affective evaluation and phenotypic description of a series of genetically confirmed CANVAS. Background: Cerebellar ataxia, neuropathy and…A Week in the Life with Parkinson’s Disease: A Holistic Overview from Four Digital Technologies
Objective: To showcase a day in the life of a person with Parkinson’s disease (PD) using four multimodal digital technologies. Background: Assessments of PD are…Has the COVID-19 pandemic had an impact on Functional Movement Disorders phenotype?: experience from a specialized Unit in Spain.
Objective: To assess the prevalence of paroxysmal functional movement disorders (PFMD) seen in a specialized Unit before and after the COVID-19 pandemic. Background: COVID-19 pandemic…Eye closure during tasks in blepharospasm (BSP)
Objective: To quantify modulation of eye closure rates during activities of daily living in individuals with BSP and asymptomatic individuals with and without family history…A STUDY OF CLINICAL SPECTRUM, RISK FACTORS AND OUTCOME OF DRUG-INDUCED MOVEMENT DISORDERS
Objective: We aimed to characterize the spectrum of DIMDs, and the culprit agents commonly encountered in the movement disorder clinic. We also set out to…Video-guided Optimization of Stimulation Settings in Patients with Parkinson’s Disease and Deep Brain Stimulation
Objective: To investigate whether video-based evaluations of motor control and changes of predefined stimulation parameters via patient programmer can improve motor status in Parkinson’s disease…Correlation between 3 Tesla Brain MRI Nigrosome-1 imaging and SPECT 123I-Ioflupane in parkinsonian disorders
Objective: To correlate nigrosome-1 (NG1) imaging and SPECT 123I-Ioflopane findings to determine the feasibility and diagnostic value of NG1 imaging in a real-world clinical setting.…Impact on non-motor symptoms, cognition, and QoL after 1-year of DBS for Parkinson’s Disease: An interim report from the ADROIT NAPA sub-study
Objective: To present the impact on cognition, quality of life, and non-motor symptoms after 1-year of DBS for Parkinson’s Disease through the ADROIT post-market study.…Edentulous stereotypy: Common lacunae in the identification of an old malady
Objective: To characterize the common errors or pitfalls in the recognition of edentulous stereotypy Background: Edentulous stereotypy is a well-characterized abnormal movement of the jaw…
- « Previous Page
- 1
- …
- 629
- 630
- 631
- 632
- 633
- …
- 1734
- Next Page »